Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
NCT ID: NCT05025774
Last Updated: 2025-11-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
90 participants
OBSERVATIONAL
2025-03-14
2026-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Blood Flow Restriction Aerobic Exercise on Inflammation, Hypoxia, Exercise Capacity, and Lung Function in COPD
NCT07261293
S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer
NCT00090961
Nurse Managed Sequential Strength Training and Bicycle Training in Chronic Obstructive Pulmonary Disease (COPD)
NCT01058213
Is Patients With Pulmonary Disease Benefit a Program With Yogic Exercises?
NCT02233114
Pulmonary Rehabilitation in Patients Before Lung Transplantation (LTx)
NCT00962078
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case
Adolescent or young adult acute lymphoblastic leukemia survivor, OR living with chronic lung disease of prematurity, OR living with heart transplant
Physical activity
Participant Reported Physical Activity and Outcomes (completed via REDCap or on paper)
Control
14-25 years old healthy individuals who are ambulatory without assistance. We may enroll younger subjects but we wish to subjects to match our patient population
Physical activity
Participant Reported Physical Activity and Outcomes (completed via REDCap or on paper)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical activity
Participant Reported Physical Activity and Outcomes (completed via REDCap or on paper)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Acute lymphoblastic leukemia survivor, OR living with chronic lung disease of prematurity, OR living with heart transplant
* 8-25 years old
* Height: ≥ 48 inches
* Ambulatory without assistance
* English speaking
* Normotensive (\<95th percentile for age; okay if managed with antihypertensive medication)
* SpO2 \>92%
* Not pregnant
* ALL survivor specific: must have completed therapy ≥ 3 months prior to study entry
* Controls
* 8-25 years old
* Height: ≥ 48 inches
* Ambulatory without assistance
* English speaking
* No history of arrhythmia or known cardiac dysfunction at baseline
* Normotensive (\<95th percentile for age; okay if managed with antihypertensive medication)
* SpO2 \>95%
* Not pregnant
Exclusion Criteria
* ALL specific: received cranial radiation, bone marrow transplant recipients
* Investigator or patient's primary physician deems the patient unsuitable for the study
* Controls:
* History of malignancy, CLD or HT or any other diagnosis which may reduce cardiorespiratory function
* Investigator deems the patient unsuitable for the study
8 Years
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Masonic Cancer Center, University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pianosi Paolo, MD
Role: PRINCIPAL_INVESTIGATOR
Masonic Children's Hospital, University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Masonic Cancer Center
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PEDS-2021-29482
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.